Estrella Immunopharma, Inc. SEC filings ESLA
Estrella Immunopharma, Inc. has 258 filings in SEC EDGAR's recent list, going back to Feb 19, 2021. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 3 | Initial insider ownership | Nov 3, 2026 | Oct 25, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 29, 2026 | Oct 25, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 8, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 25, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 18, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2026 | Aug 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2026 | Jun 29, 2026 |
| DEF 14A | Proxy statement | May 27, 2026 | Jun 29, 2026 |
| 10-Q | Quarterly report | May 18, 2026 | Mar 31, 2026 |
| NT 10-Q | Notification of late filing | May 18, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Apr 29, 2026 | Sep 11, 2025 |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| 424B3 | Prospectus | Feb 13, 2026 | — |
| EFFECT | Filing | Jan 23, 2026 | — |
| CORRESP | Letter to the SEC | Jan 22, 2026 | — |
| S-1/A | Amended registration statement | Jan 22, 2026 | — |
| S-1/A | Amended registration statement | Jan 16, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jan 13, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 6, 2026 | Jan 5, 2026 |
| 424B5 | Prospectus supplement | Jan 6, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2025 | — |
| S-1 | Registration statement | Dec 22, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 4, 2025 | Dec 4, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 3, 2025 |
| 3 | Initial insider ownership | Oct 1, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Other events
|
Sep 29, 2025 | Sep 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2025 | Sep 22, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 7, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Other events
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 3, 2025 | May 30, 2025 |
| 8-K |
Current report
Other events
|
May 29, 2025 | May 29, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice
|
May 2, 2025 | Apr 30, 2025 |
| 10-KT | Transition report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Feb 21, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Other events
|
Feb 20, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Oct 30, 2024 |
| 4 | Insider transaction | Feb 14, 2025 | Oct 30, 2024 |
| S-8 | Employee stock plan registration | Dec 23, 2024 | — |
| EFFECT | Filing | Dec 19, 2024 | — |
| CORRESP | Letter to the SEC | Dec 17, 2024 | — |
| 424B3 | Prospectus | Dec 17, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| S-3 | Shelf registration | Dec 12, 2024 | — |
| 424B3 | Prospectus | Dec 9, 2024 | — |
| 8-K |
Current report
Material agreement
|
Dec 6, 2024 | Dec 4, 2024 |
| 424B3 | Prospectus | Nov 27, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 26, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 25, 2024 | Nov 25, 2024 |
| 424B3 | Prospectus | Nov 18, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K/A |
Amended current report
Material agreement, Officer or director change
|
Nov 7, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2024 | Nov 1, 2024 |
| 10-K/A | Amended annual report | Oct 28, 2024 | Jun 30, 2024 |
| 424B3 | Prospectus | Oct 2, 2024 | — |
| 10-K | Annual report | Sep 27, 2024 | Jun 30, 2024 |
| 3 | Initial insider ownership | Aug 23, 2024 | Aug 14, 2024 |
| 424B3 | Prospectus | Aug 21, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 20, 2024 | Aug 14, 2024 |
| 424B3 | Prospectus | Aug 6, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 6, 2024 | Jul 31, 2024 |
| 424B3 | Prospectus | Jul 2, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 2, 2024 | Jun 26, 2024 |
| 424B3 | Prospectus | May 15, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2024 | Apr 10, 2024 |
| 424B3 | Prospectus | Mar 11, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 8, 2024 |
| 424B3 | Prospectus | Mar 7, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 7, 2024 | Mar 4, 2024 |
| 424B3 | Prospectus | Feb 16, 2024 | — |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 424B3 | Prospectus | Feb 12, 2024 | — |
| 8-K |
Current report
Auditor change
|
Feb 2, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Other events
|
Jan 30, 2024 | Jan 30, 2024 |
| EFFECT | Filing | Dec 28, 2023 | — |
| 424B3 | Prospectus | Dec 28, 2023 | — |
| CORRESP | Letter to the SEC | Dec 27, 2023 | — |
| S-1/A | Amended registration statement | Dec 18, 2023 | — |
| CORRESP | Letter to the SEC | Dec 15, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2023 | — |
| 10-Q | Quarterly report | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | Notification of late filing | Nov 15, 2023 | Sep 30, 2023 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Nov 14, 2023 | Sep 29, 2023 |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| S-1/A | Amended registration statement | Nov 13, 2023 | — |
| SC 13D | Ownership over 5% (active) | Oct 30, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2023 | — |
| S-1 | Registration statement | Oct 11, 2023 | — |
| 3 | Initial insider ownership | Oct 10, 2023 | Sep 29, 2023 |
| 3 | Initial insider ownership | Oct 10, 2023 | Sep 29, 2023 |
| 3 | Initial insider ownership | Oct 10, 2023 | Sep 29, 2023 |
| 3 | Initial insider ownership | Oct 10, 2023 | Sep 29, 2023 |
| 3 | Initial insider ownership | Oct 10, 2023 | Sep 29, 2023 |
| 3 | Initial insider ownership | Oct 10, 2023 | Sep 29, 2023 |
| 3 | Initial insider ownership | Oct 10, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
|
Oct 5, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Sep 29, 2023 |
| 25-NSE | Delisting notice | Oct 5, 2023 | — |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 29, 2023 |
| 425 | Current report | Sep 20, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 20, 2023 | Sep 14, 2023 |
| 425 | Current report | Sep 18, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 18, 2023 | Sep 18, 2023 |
| 425 | Current report | Aug 18, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 18, 2023 | Aug 18, 2023 |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| 425 | Current report | Aug 1, 2023 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Aug 1, 2023 | Jul 31, 2023 |
| DEFA14A | Additional proxy material | Jul 26, 2023 | — |
| 425 | Current report | Jul 26, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 26, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 21, 2023 | Jul 20, 2023 |
| 425 | Current report | Jul 19, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jul 19, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jul 19, 2023 | Jul 17, 2023 |
| SEC STAFF LETTER | Filing | Jul 18, 2023 | — |
| DEFA14A | Additional proxy material | Jul 12, 2023 | — |
| 8-K |
Current report
Other events
|
Jul 12, 2023 | Jul 11, 2023 |
| EFFECT | Filing | Jul 11, 2023 | — |
| 424B3 | Prospectus | Jul 11, 2023 | — |
| S-4/A | Amendment no. 7 to form s-4 | Jul 10, 2023 | — |
| S-4/A | Amendment no. 6 to form s-4 | Jul 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 6, 2023 | — |
| CORRESP | Letter to the SEC | Jun 30, 2023 | — |
| S-4/A | Form s-4/a | Jun 30, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2023 | — |
| 8-K |
Current report
Listing notice
|
Jun 23, 2023 | Jun 22, 2023 |
| 425 | Form 425 | Jun 21, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jun 20, 2023 | Jun 16, 2023 |
| UPLOAD | Letter from the SEC | Jun 16, 2023 | — |
| DEF 14A | Proxy statement | Jun 16, 2023 | Jun 16, 2023 |
| S-4/A | Form s-4/a | Jun 16, 2023 | — |
| CORRESP | Letter to the SEC | Jun 15, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 9, 2023 | Jun 6, 2023 |
| PRER14A | Prer 14a | Jun 2, 2023 | — |
| PRE 14A | Preliminary proxy statement | May 25, 2023 | May 25, 2023 |
| 425 | Form 425 | May 19, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
May 19, 2023 | May 19, 2023 |
| 10-Q | Quarterly report | May 18, 2023 | Mar 31, 2023 |
| UPLOAD | Letter from the SEC | May 17, 2023 | — |
| NT 10-Q | Form nt 10-q | May 16, 2023 | May 15, 2023 |
| SEC STAFF LETTER | Filing | May 9, 2023 | — |
| S-4/A | Form s-4/a | May 2, 2023 | — |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| 425 | Form 425 | Apr 26, 2023 | — |
| 8-K |
Current report
Material agreement
|
Apr 26, 2023 | Apr 26, 2023 |
| 425 | Form 425 | Apr 24, 2023 | — |
| 8-K |
Current report
Material agreement
|
Apr 24, 2023 | Apr 20, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 21, 2023 | Apr 19, 2023 |
| 425 | Form 425 | Apr 13, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Apr 13, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 5, 2023 | Apr 3, 2023 |
| 425 | Form 425 | Mar 20, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Mar 20, 2023 | Mar 17, 2023 |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 10, 2023 | — |
| 425 | Form 425 | Mar 8, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 3, 2023 | Mar 3, 2023 |
| 425 | Form 425 | Feb 21, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Feb 21, 2023 | Feb 17, 2023 |
| SEC STAFF LETTER | Filing | Feb 17, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| S-4/A | Filing | Feb 3, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2023 | — |
| 425 | Filing | Jan 24, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jan 24, 2023 | Jan 19, 2023 |
| 3 | Initial insider ownership | Jan 9, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Other events
|
Jan 5, 2023 | Dec 29, 2022 |
| UPLOAD | Letter from the SEC | Dec 29, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 29, 2022 | Dec 22, 2022 |
| S-4/A | Form s-4/a | Dec 19, 2022 | — |
| CORRESP | Letter to the SEC | Dec 16, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| DEF 14A | Proxy statement | Dec 6, 2022 | Dec 6, 2022 |
| PRER14A | Filing | Dec 2, 2022 | — |
| PRE 14A | Preliminary proxy statement | Nov 25, 2022 | Nov 25, 2022 |
| UPLOAD | Letter from the SEC | Nov 14, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| S-4 | Registration for a merger or exchange | Oct 18, 2022 | — |
| 8-K |
Current report
Auditor change
|
Oct 11, 2022 | Oct 10, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 3, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ESLA (Nasdaq), ESLAW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Emeryville, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1844417
- Former names
- TradeUP Acquisition Corp. (until Sep 20, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.